Discover 2,221 paid clinical trials in Hayward, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,221
Active & Responsive
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment
for
Alagille Syndrome
Location: San Francisco CA, Los Angeles CA, El Paso TX, Dallas TX,
Sponsor: Ipsen
Sex: All
Age: 0+
Code: NCT06850038
Recruiting
Active & Responsive
Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)
for
Congenital Diaphragmatic Hernia
Location: San Francisco CA
Sponsor: Hanmin Lee
Sex: Female
Age: 18+
Code: NCT04583644
Recruiting
Active & Responsive
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Location: San Francisco CA, Los Angeles CA, San Diego CA,
Sponsor: Mezzion Pharma Co. Ltd
Sex: All
Age: 12 - 18
Code: NCT05918211
Phase 3, Recruiting
Active & Responsive
Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers
for
Healthy Participants With Lower-than-average Mental Well-being
Location: San Francisco CA
Sponsor: Robin Carhart-Harris, PhD, MA
Sex: All
Age: 21 - 70
Code: NCT06626139
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for
Carcinoma, Non-Small-Cell Lung
Location: San Francisco CA, Los Angeles CA, Long Beach CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06623422
Phase 3, Recruiting
Active & Responsive
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
for
Bladder Cancer
Location: San Francisco CA, Salt Lake City UT, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07232602
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
for
Colorectal Cancer, Colorectal Cancer (CRC),
Location: San Francisco CA, Los Angeles CA, Duarte CA, Phoenix AZ,
Sponsor: Cartography Biosciences
Sex: All
Age: 18+
Code: NCT07321106
Phase 1, Recruiting
Active & Responsive
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
for
Dravet Syndrome
Location: San Francisco CA, Los Angeles CA, Orange CA,
Sponsor: Stoke Therapeutics, Inc
Sex: All
Age: 2 - 17
Code: NCT06872125
Phase 3, Recruiting
Active & Responsive
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
for
Congenital Adrenal Hyperplasia,
Location: San Francisco CA, Fort Worth TX, Minneapolis MN,
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All
Age: 1 - 17
Code: NCT07159841
Phase 2, Phase 3, Recruiting
Active & Responsive
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
for
Lumbar Disc Disease
Location: Walnut Creek CA, Santa Monica CA, Greenwood Village CO,
Sponsor: BioRestorative Therapies
Sex: All
Age: 18+
Code: NCT04042844
Phase 2, Recruiting
Active & Responsive
A Study of Brenipatide in Participants With Opioid Use Disorder
for
Opioid Use Disorder
Location: San Francisco CA, Fountain Valley CA, Phoenix AZ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07420283
Phase 2, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
for
Asthma
Location: Walnut Creek CA, San Jose CA, Lancaster CA,
Sponsor: Pfizer
Sex: All
Age: 18 - 70+
Code: NCT06977581
Phase 2, Recruiting
Active & Responsive
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Location: San Francisco CA, Rancho Mirage CA, Kansas City KS,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06538064
Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Stanford CA, San Francisco CA, Sacramento CA,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase 2, Phase 3, Recruiting
Active & Responsive
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Stanford CA, San Francisco CA, Duarte CA, Orange CA,
Sponsor: Massive Bio, Inc.
Sex: All
Age: 0+
Code: NCT03452774
Recruiting
Active & Responsive
A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
for
Phelan-McDermid Syndrome
Location: Palo Alto CA, San Rafael CA, Glendale CA, San Diego CA,
Sponsor: Neuren Pharmaceuticals Limited
Sex: All
Age: 3 - 12
Code: NCT07281079
Phase 3, Recruiting
Active & Responsive
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
for
Solid Tumor
Location: Stanford CA, Santa Monica CA, El Segundo CA,
Sponsor: Alyssum Therapeutics
Sex: All
Age: 18+
Code: NCT06234098
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: San Francisco CA, Reno NV, Los Angeles CA, Duarte CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase 3, Recruiting
Active & Responsive
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
for
Prostate Cancer Castration-resistant Prostate Cancer,
Location: San Francisco CA, West Valley City UT, Irving TX,